BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15930485)

  • 21. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.
    Meyer BJ; Hammervold T; Rustan AC; Howe PR
    Lipids; 2007 Mar; 42(2):109-15. PubMed ID: 17393216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial.
    Dunbar RL; Nicholls SJ; Maki KC; Roth EM; Orloff DG; Curcio D; Johnson J; Kling D; Davidson MH
    Lipids Health Dis; 2015 Sep; 14():98. PubMed ID: 26328624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial.
    Geppert J; Kraft V; Demmelmair H; Koletzko B
    Br J Nutr; 2006 Apr; 95(4):779-86. PubMed ID: 16571158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits of foods supplemented with vegetable oils rich in α-linolenic, stearidonic or docosahexaenoic acid in hypertriglyceridemic subjects: a double-blind, randomized, controlled trail.
    Dittrich M; Jahreis G; Bothor K; Drechsel C; Kiehntopf M; Blüher M; Dawczynski C
    Eur J Nutr; 2015 Sep; 54(6):881-93. PubMed ID: 25216712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy.
    Stark KD; Holub BJ
    Am J Clin Nutr; 2004 May; 79(5):765-73. PubMed ID: 15113713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial.
    Stark KD; Park EJ; Maines VA; Holub BJ
    Am J Clin Nutr; 2000 Aug; 72(2):389-94. PubMed ID: 10919932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of plant sterols and different low doses of omega-3 fatty acids from fish oil on lipoprotein subclasses.
    Jacobs DM; Mihaleva VV; van Schalkwijk DB; de Graaf AA; Vervoort J; van Dorsten FA; Ras RT; Demonty I; Trautwein EA; van Duynhoven J
    Mol Nutr Food Res; 2015 Sep; 59(9):1745-57. PubMed ID: 26019023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fish oil supplementation alters circulating eicosanoid concentrations in young healthy men.
    Zulyniak MA; Perreault M; Gerling C; Spriet LL; Mutch DM
    Metabolism; 2013 Aug; 62(8):1107-13. PubMed ID: 23522836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid effects of a dietary supplement softgel capsule containing plant sterols/stanols in primary hypercholesterolemia.
    Maki KC; Lawless AL; Reeves MS; Kelley KM; Dicklin MR; Jenks BH; Shneyvas E; Brooks JR
    Nutrition; 2013 Jan; 29(1):96-100. PubMed ID: 22796122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients.
    Goh YK; Jumpsen JA; Ryan EA; Clandinin MT
    Diabetologia; 1997 Jan; 40(1):45-52. PubMed ID: 9028717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
    Goyens PL; Mensink RP
    Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation.
    Lindi V; Schwab U; Louheranta A; Laakso M; Vessby B; Hermansen K; Storlien L; Riccardi G; A Rivellese A;
    Mol Genet Metab; 2003 May; 79(1):52-60. PubMed ID: 12765846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes.
    Taghizadeh M; Jamilian M; Mazloomi M; Sanami M; Asemi Z
    J Clin Lipidol; 2016; 10(2):386-93. PubMed ID: 27055970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
    Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A
    Am J Clin Nutr; 1997 Sep; 66(3):649-59. PubMed ID: 9280188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review.
    Jacobson TA; Glickstein SB; Rowe JD; Soni PN
    J Clin Lipidol; 2012; 6(1):5-18. PubMed ID: 22264569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
    Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH
    Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.